MOTPOLY XR

NDC 73289-0064 · Aucta Pharmaceuticals, Inc.

Generic namelacosamide

Dosage formCAPSULE, EXTENDED RELEASE

RouteORAL

Active ingredient(s)LACOSAMIDE

Strength150 mg/1

Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]

DEA scheduleCV

Marketing categoryNDA

Packages

73289-0064-2 — 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0064-2)

FDA lists these products with the same active ingredient.

71921-223 — Lacosamide, 71921-411 — Lacosamide Oral, 72162-2637 — Lacosamide, 72205-034 — Lacosamide, 72205-220 — Lacosamide, 72266-242 — Lacosamide, 72603-263 — LACOSAMIDE, 72603-305 — Lacosamide, 72865-235 — LACOSAMIDE, 73289-0063 — lacosamide, 73289-0065 — lacosamide, 80425-0510 — Lacosamide, 81033-427 — Lacosamide, 81033-428 — Lacosamide, 82804-990 — Lacosamide, 82804-991 — Lacosamide, 82804-992 — Lacosamide, 82804-993 — Lacosamide, 82983-427 — Lacosamide, 83090-012 — lacosamide, +141 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.